Capecitabine in combination with irinotecan (XELIRI), administered as a 2-weekly schedule, as first-line chemotherapy for patients with metastatic colorectal cancer: A phase II study of the Spanish GOTI group
- Garcia-Alfonso, P.
- Mũoz-Martin, A.
- Mendez-Urẽa, M.
- Quiben-Pereira, R.
- Gonzalez-Flores, E.
- Perez-Manga, G.
ISSN: 0007-0920, 1532-1827
Argitalpen urtea: 2009
Alea: 101
Zenbakia: 7
Orrialdeak: 1039-1043
Mota: Artikulua